Aurobindo Pharma Ltd - An Overview of Profitability

Case Code: FINC216 Case Length: 7 Pages Period: - Pub Date: 2025 Teaching Note: Available

Price: Rs.300 Organization: Aurobindo Pharma Industry: Pharmaceuticals & Biotech Countries: India Themes: Financial Analysis

Abstract Case Intro 1 Case Intro 2 Excerpts

Expenses of Aurobindo Pharma Limited

Of all the operational expenses incurrred by the company, ‘other operational expenses’ constituted the major component (Refer to Figure-I for Components of various operational expenses incurred by Aurobindo Pharma Limited during the fiscal years 2022-23 and 2023-24). The other expenses witnessed an uneven trend over five years from 2019..

Buy this case study (Please select any one of the payment options)

Price: Rs.300 Instant Download

Price: Rs.300 Express Checkout

PayPal (7 USD)